论文部分内容阅读
Recently, efforts have been made to reevaluate old drugs with a view to determining their potential as an alternative and relatively rapid strategy for drug discovery.We have adopted a bioinformatics based platform (Connectivity Map and L1000 profiling) to rapidly place old drugs, including small molecules and Chinese herbal medicines, into clinical trial.